AUGUSTINE THERAPEUTICS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AUGUSTINE THERAPEUTICS
Largest movements
- Current investments +€26.5m
new in 2025: €26.5m
- Cash -€7.1m
down €7.1m (-91.5%), from €7.8m to €656,414
mainly Current investments (-€26.5m) and Net result for the year (-€14.8m)
- Receivables within one year +€853,202
up €853,202 (+588.4%), from €145,000 to €998,202
of which Other amounts receivable: +€548,555
- Deferred charges and accrued income +€659,236
up €659,236 (+1611.5%), from €40,907 to €700,144
- Tangible fixed assets +€601,858
up €601,858 (+343.5%), from €175,237 to €777,095
- Contributions +€37.0m
up €37.0m (+241.4%), from €15.3m to €52.3m
- Profit (loss) carried forward -€14.8m
down €14.8m (-172.7%), from -€8.6m to -€23.4m
- Trade debts -€426,820
down €426,820 (-25.1%), from €1.7m to €1.3m
- Depreciation +€6.4m
up €6.4m (+106.0%), from €6.1m to €12.5m
- Staff costs +€744,166
up €744,166 (+92.0%), from €809,077 to €1.6m
- Financial income +€514,545
up €514,545 (+7750.8%), from €6,639 to €521,184
- Taxes -€218,634
down €218,634 (-81.3%), from -€268,973 to -€487,607
- Financial charges -€113,481
down €113,481 (-49.7%), from €228,111 to €114,630
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €8,818,803 | €30,907,588 | +€22.1m | +250.5% |
| Fixed assets | 21/28 | €176,920 | €943,555 | +€766,635 | +433.3% |
| Intangible fixed assets | 21 | €1,682 | €721 | -€961 | -57.1% |
| Tangible fixed assets | 22/27 | €175,237 | €777,095 | +€601,858 | +343.5% |
| Plant, machinery and equipment | 23 | €93,951 | €323,129 | +€229,177 | +243.9% |
| Furniture and vehicles | 24 | €81,286 | €103,418 | +€22,132 | +27.2% |
| Leasing and similar rights | 25 | - | €257,280 | +€257,280 | |
| Other tangible fixed assets | 26 | - | €93,269 | +€93,269 | |
| Financial fixed assets | 28 | - | €165,738 | +€165,738 | |
| Current assets | 29/58 | €8,641,883 | €29,964,034 | +€21.3m | +246.7% |
| Amounts receivable after more than one year | 29 | €704,924 | €1,109,274 | +€404,350 | +57.4% |
| Other amounts receivable | 291 | €704,924 | €1,109,274 | +€404,350 | +57.4% |
| Amounts receivable within one year | 40/41 | €145,000 | €998,202 | +€853,202 | +588.4% |
| Trade receivables | 40 | €0 | €304,647 | +€304,647 | |
| Other amounts receivable | 41 | €145,000 | €693,555 | +€548,555 | +378.3% |
| Current investments | 50/53 | - | €26,500,000 | +€26.5m | |
| Cash at bank and in hand | 54/58 | €7,751,051 | €656,414 | -€7.1m | -91.5% |
| Deferred charges and accrued income | 490/1 | €40,907 | €700,144 | +€659,236 | +1611.5% |
| Total equity and liabilities | 10/49 | €8,818,803 | €30,907,588 | +€22.1m | +250.5% |
| Equity | 10/15 | €6,767,866 | €28,979,107 | +€22.2m | +328.2% |
| Contributions | 10/11 | €15,329,665 | €52,329,665 | +€37.0m | +241.4% |
| Capital | 10 | €15,329,665 | €52,329,665 | +€37.0m | +241.4% |
| Issued capital | 100 | €15,329,665 | €52,329,665 | +€37.0m | +241.4% |
| Profit (loss) carried forward | 14 | -€8,561,799 | -€23,350,558 | -€14.8m | -172.7% |
| Amounts payable | 17/49 | €2,050,937 | €1,928,481 | -€122,455 | -6.0% |
| Amounts payable after more than one year | 17 | €0 | €172,352 | +€172,352 | |
| Financial debts | 170/4 | €0 | €172,352 | +€172,352 | |
| Amounts payable within one year | 42/48 | €2,005,352 | €1,756,129 | -€249,223 | -12.4% |
| Current portion of amounts payable after more than one year | 42 | - | €84,767 | +€84,767 | |
| Trade debts | 44 | €1,700,227 | €1,273,407 | -€426,820 | -25.1% |
| Suppliers | 440/4 | €1,700,227 | €1,273,407 | -€426,820 | -25.1% |
| Taxes, remuneration and social security | 45 | €305,125 | €397,954 | +€92,829 | +30.4% |
| Taxes | 450/3 | - | €6,626 | +€6,626 | |
| Remuneration and social security | 454/9 | €305,125 | €391,328 | +€86,203 | +28.3% |
| Accrued charges and deferred income | 492/3 | €45,585 | €0 | -€45,585 | -100.0% |
| Remuneration, social security and pensions | 62 | €809,077 | €1,553,243 | +€744,166 | +92.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,054,325 | €12,469,800 | +€6.4m | +106.0% |
| Other operating charges | 640/8 | €1,379 | €3,128 | +€1,749 | +126.9% |
| Gross operating margin | 9900 | -€1,744,519 | -€1,656,750 | +€87,769 | +5.0% |
| Operating profit (loss) | 9901 | -€8,609,300 | -€15,682,920 | -€7.1m | -82.2% |
| Financial income | 75/76B | €6,639 | €521,184 | +€514,545 | +7750.8% |
| Recurring financial income | 75 | €6,639 | €521,184 | +€514,545 | +7750.8% |
| Financial charges | 65/66B | €228,111 | €114,630 | -€113,481 | -49.7% |
| Recurring financial charges | 65 | €228,111 | €114,630 | -€113,481 | -49.7% |
| Profit (loss) for the period before taxes | 9903 | -€8,830,772 | -€15,276,366 | -€6.4m | -73.0% |
| Income taxes | 67/77 | -€268,973 | -€487,607 | -€218,634 | -81.3% |
| Profit (loss) for the period | 9904 | -€8,561,799 | -€14,788,759 | -€6.2m | -72.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€8,561,799 | -€14,788,759 | -€6.2m | -72.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.